Related Experiment Video

Updated: Oct 2, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

[Recent data on the mechanism of action of synthetic antiestrogens]

H Rochefort

    Biochimie
    |February 1, 1982
    PubMed

    Insights

    Synthetic antiestrogens like Tamoxifen block estrogen action in breast cancer cells by interacting with the estrogen receptor (RE). Their precise anti-tumor effects, beyond inhibiting estrogen, are still under investigation.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Pharmacology

    Context:

    • Postmenopausal breast cancer treatment relies on synthetic antiestrogens.
    • Tamoxifen (Nolvadex) is a key therapeutic agent.
    • Understanding drug mechanisms is crucial for treatment optimization.

    Purpose:

    • To review the cellular and molecular mechanisms of synthetic antiestrogens.
    • To elucidate their interaction with the estrogen receptor (RE).
    • To discuss the controversial aspects of their anti-tumoral effects.

    Summary:

    • Synthetic antiestrogens, such as Tamoxifen, primarily target breast cancer cells by binding to the estrogen receptor (RE).
    • They compete with estrogens, leading to partial activation, nuclear translocation, and altered gene expression.
    • The exact anti-tumoral mechanisms remain debated, potentially involving RE-mediated cytotoxicity or other pathways.

    Impact:

    • Provides a comprehensive overview of antiestrogen action at the cellular and molecular levels.
    • Highlights the complexities and ongoing research into their therapeutic effects.
    • Informs future drug development and treatment strategies for breast cancer.

    More Related Videos

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

    Published on: August 13, 2019

    Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay06:07

    Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

    Published on: June 7, 2020

    Related Concept Videos

    Principles of Drug Action01:24

    Principles of Drug Action

    Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
    Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
    Transducer Mechanism: Nuclear Receptors01:31

    Transducer Mechanism: Nuclear Receptors

    Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
    About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
    Drug-Receptor Interaction: Agonist01:25

    Drug-Receptor Interaction: Agonist

    Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
    Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
    Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

    Direct-Acting Cholinergic Agonists: Pharmacokinetics

    Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
    Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

    Indirect-Acting Cholinergic Agonists: Mechanism of Action

    Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
    Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
    Structure-Activity Relationships and Drug Design01:28

    Structure-Activity Relationships and Drug Design

    Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
    SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...